SUBSCRIBE TO TMCnet
TMCnet - World's Largest Communications and Technology Community

TMCNet:  Research and Markets: Controlled Release Drug Delivery Market & Pipeline Insight Report 2014

[May 26, 2014]

Research and Markets: Controlled Release Drug Delivery Market & Pipeline Insight Report 2014

DUBLIN --(Business Wire)--

Research and Markets (http://www.researchandmarkets.com/research/t6jmqz/controlled) has announced the addition of the "Controlled Release Drug Delivery Market & Pipeline Insight" report to their offering.

Controlled drug delivery refers to a system combining the formulation components and devices with the objective of releasing a drug at a predictable rate. The controlled drug delivery system makes it possible in vivo, irrespective of whether the administration of the drug is done through the injected or non-injected route. A controlled drug delivery is observed to occur when a natural or a synthetic polymer is carefully combined with a drug in a manner which enables the release of the active agent from the material in the pre-specified method.

As compared to other forms of targeted drug delivery, the controlled drug delivery system is considered to be more appropriate as it has been successful in delivering the drug at a predetermined rate, locally or systemically for a predetermined priod of time. Two major advantages offered by this system include the maintenance of therapeutically optimum drug concentrations in the plasma without major fluctuations through the zero-order release and the absence of the need for frequent single dose administrations. Other advantages include reduced delivery times, which help in improving patient compliance rate, improved levels of clinical efficacy to reduce the side effects and increased bioavailability.


"Controlled Release Drug Delivery Market & Pipeline Insight" Report Highlights:

  • Controlled Release Drug Delivery Market Overview
  • Controlled Release Drug Delivery Mechanism
  • Clinical Pipeline by Phase & Target (News - Alert) Indications
  • Drug Profiles in Report: 451
  • Drug Profile in Active Clinical Phase (Research till Registration): 234
  • Majority of Controlled Release Drug in Phase-II Development: 58
  • Marketed Controlled Release Drugs: 140
  • Suspended & Discontinued Drug Profiles

Key Topics Covered:

1. Introduction to Controlled Release Drug Delivery

2. Controlled Release Drug Delivery Mechanism

3. Why Need for Controlled Release Drug Delivery?

4. Controlled Release Drug Delivery Market Overview

5. Controlled Release Drug Delivery Market Dynamics

6. Controlled Release Drug Delivery Market Future Opportunities

7. Controlled Release Drug Clinical Pipeline by Phase & Target Indications

8. Marketed Controlled Release Drugs

9. Suspended & Discontinued Controlled Release Drug Profiles

10. Competitive Landscape

  • Allergan
  • BioAlliance Pharma
  • Collegium Pharmaceutical
  • Controlled Therapeutics (Ferring Pharmaceuticals)
  • Cosmo Pharmaceuticals
  • Egalet
  • Encore Therapeutics
  • Flamel Technologies
  • GlaxoSmithKline
  • Novartis
  • Pfizer
  • iCeutica

For more information visit http://www.researchandmarkets.com/research/t6jmqz/controlled


[ Back To Technology News's Homepage ]

OTHER NEWS PROVIDERS







Technology Marketing Corporation

800 Connecticut Ave, 1st Floor East, Norwalk, CT 06854 USA
Ph: 800-243-6002, 203-852-6800
Fx: 203-866-3326

General comments: tmc@tmcnet.com.
Comments about this site: webmaster@tmcnet.com.

STAY CURRENT YOUR WAY

© 2014 Technology Marketing Corporation. All rights reserved.